These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 16084954)
1. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377 [TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma. Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706 [TBL] [Abstract][Full Text] [Related]
4. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1). Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203 [TBL] [Abstract][Full Text] [Related]
7. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Migita T; Oda Y; Naito S; Tsuneyoshi M Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421 [TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171 [TBL] [Abstract][Full Text] [Related]
11. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis. Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121 [TBL] [Abstract][Full Text] [Related]
12. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Kirla RM; Haapasalo HK; Kalimo H; Salminen EK Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606 [TBL] [Abstract][Full Text] [Related]
13. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer. Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807 [TBL] [Abstract][Full Text] [Related]
15. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation. Pruneri G; Mazzarol G; Fabris S; Del Curto B; Bertolini F; Neri A; Viale G Mod Pathol; 2003 Sep; 16(9):886-92. PubMed ID: 13679452 [TBL] [Abstract][Full Text] [Related]
17. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma. Zhang C; Zhang P; Hao J; Quddus MR; Steinhoff MM; Sung CJ Breast J; 2005; 11(1):2-8. PubMed ID: 15647071 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hasegawa T; Yokoyama R; Matsuno Y; Shimoda T; Hirohashi S Hum Pathol; 2001 Mar; 32(3):257-63. PubMed ID: 11274633 [TBL] [Abstract][Full Text] [Related]
19. Molecular control of the cell cycle in cancer: biological and clinical aspects. Møller MB Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]